These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18056168)

  • 1. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of thymidylate synthase in human non-small cell lung cancer.
    Otake Y; Tanaka F; Yanagihara K; Hitomi S; Okabe H; Fukushima M; Wada H
    Jpn J Cancer Res; 1999 Nov; 90(11):1248-53. PubMed ID: 10622537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
    Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
    Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.
    Papavassiliou KA; Sofianidi AA; Gogou VA; Anagnostopoulos N; Papavassiliou AG
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic Profiling for Prognostic Biomarkers in Early-Stage Squamous Cell Lung Cancer (SqCLC).
    Šutić M; Dmitrović B; Jakovčević A; Džubur F; Oršolić N; Debeljak Ž; Försti A; Seiwerth S; Brčić L; Madzarac G; Samaržija M; Jakopović M; Knežević J
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling.
    Gobbi G; Grieco A; Torricelli F; Sauta E; Santandrea G; Zanetti E; Fantini V; Reggiani F; Strocchi S; Paci M; Vohra M; Saladi SV; Ambrosetti DC; Ciarrocchi A; Sancisi V
    Cell Death Dis; 2023 Nov; 14(11):752. PubMed ID: 37980331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer.
    Bugide S; Edwards YJK; Gupta R; Green MR; Wajapeyee N
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2218118120. PubMed ID: 36652476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
    Yang C; Chen L; Niu Q; Ge Q; Zhang J; Tao J; Zhou J; Liang C
    Cancer Cell Int; 2022 Dec; 22(1):382. PubMed ID: 36471446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression.
    Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry.
    Du K; Sun S; Jiang T; Liu T; Zuo X; Xia X; Liu X; Wang Y; Bu Y
    Int J Biol Sci; 2022; 18(10):4151-4170. PubMed ID: 35844795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Core Mechanism of Yiqi Yangjing Decoction Inhibiting Nonsmall-Cell Lung Cancer.
    Yi K; Zhou Y; Zhang M; Guo Y
    Evid Based Complement Alternat Med; 2022; 2022():2256671. PubMed ID: 35586682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis.
    Wu Y; Yuan J; Tu Z; Chen H
    J Oncol; 2022; 2022():3744560. PubMed ID: 35444695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-532-E2F1 feedback loop contributes to gastric cancer progression.
    Gao S; Bu X; Gao Y; Bao Z; Shi W; Luan L; Chen H; Zhang B; Tian Q; Guan W; Yang L
    Cell Death Dis; 2022 Apr; 13(4):376. PubMed ID: 35440106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma.
    Chen Y; Gong W; Dai W; Jiang H; Xu X
    Transl Cancer Res; 2021 Jun; 10(6):2801-2811. PubMed ID: 35116590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bongiovanni L; Andriessen A; Silvestri S; Porcellato I; Brachelente C; de Bruin A
    Front Vet Sci; 2021; 8():705359. PubMed ID: 34485433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2.
    Fan X; Wang Y; Jiang T; Liu T; Jin Y; Du K; Niu Y; Zhang C; Liu Z; Lei Y; Bu Y
    Oncogene; 2021 Sep; 40(37):5613-5625. PubMed ID: 34316028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Antiproliferative and Apoptosis Activity by 1,5-Bis(4-Hydroxy-3-Methoxyphenyl)1,4-Pentadiene-3-one (MS13) on Human Non-Small Cell Lung Cancer Cells.
    Wan Mohd Tajuddin WNB; Abas F; Othman I; Naidu R
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
    Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
    Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
    Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W
    Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.